GSK Senior Director Safety Pharmacology Job Collegeville PA

GSK is seeking a Senior Director of Safety Pharmacology to lead safety assessment operations at its facility in Collegeville, Pennsylvania, according to a job posting discovered August 6, 2026. The role involves overseeing the pharmacological evaluation of drug candidates to identify potential adverse effects before they reach clinical trials.

The position is based at the company’s Collegeville site, which serves as a primary hub for GSK’s research and development efforts in the United States. The Senior Director will be responsible for the strategic direction of safety pharmacology, ensuring that all testing adheres to global regulatory standards for drug safety and efficacy.

Safety pharmacology is a critical phase of the drug development pipeline. It focuses on the effects of a drug on essential organ systems, such as the cardiovascular, central nervous system, and respiratory systems, to prevent toxicity in human subjects. The Senior Director will manage these assessments to mitigate risk throughout the development lifecycle.

According to the recruitment listing, the successful candidate will lead a team of scientists and specialists. The role requires a combination of technical expertise in pharmacology and executive leadership to coordinate with other departments, including toxicology and clinical development, to ensure a cohesive safety profile for new therapeutic candidates.

The Collegeville campus is a central part of GSK’s infrastructure in Pennsylvania, hosting various functions of the company’s global pharmaceutical operations. The appointment of a Senior Director for Safety Pharmacology indicates a continued investment in the site’s capacity to handle high-level safety screenings for the company’s pipeline.